Company Profile
Centocor is a Malvern, Pennsylvania-based chemical company specializing in the research, development and commercialization of biopharmaceutical products. Founded in 1989, Centocor is a subsidiary of Janssen Pharmaceuticals, a division of Johnson & Johnson.
Centocor develops novel biopharmaceutical products to treat a variety of diseases, including autoimmune and inflammatory diseases, oncology and infectious diseases. The company brings its products to market using technologies as diverse as recombinant DNA technology, monoclonal antibodies, and cell therapies.
Centocor operates in more than 60 countries around the world and has more than 6,000 employees.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Remicade |
Immunoglobulin G,anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain),disulfide with human-mouse monoclonal cA2 light chain,dimer;Infliximab;Avakine;Remicade |
170277-31-3 | Inquiry |
CONTACT INFORMATION
Sign In for Details